Alpha Crest Capital Management LLC Nevro Corp Transaction History

Alpha Crest Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $343,820 - $448,421	8,456 New	8,456 $394,000
Q2 2022 Aug 11, 2022	SELL	$40.85 - $77.67 $262,992 - $500,039	-6,438 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$59.95 - $92.06 $163,123 - $250,495	-2,721 Reduced 29.71%	6,438 $466,000
Q4 2021 Feb 09, 2022	BUY	$81.07 - $121.29 $412,808 - $617,608	5,092 Added 125.2%	9,159 $743,000
Q3 2021 Nov 10, 2021	BUY	$101.99 - $166.36 $414,793 - $676,586	4,067 New	4,067 $473,000
Q2 2021 Aug 12, 2021	SELL	$141.6 - $179.06 $833,457 - $1.05 Million	-5,886 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$132.81 - $182.18 $781,719 - $1.07 Million	5,886 New	5,886 $821,000
Q4 2020 Feb 12, 2021	SELL	$138.17 - $184.34 $570,365 - $760,955	-4,128 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$114.09 - $145.51 $73,588 - $93,853	645 Added 18.52%	4,128 $575,000
Q2 2020 Aug 12, 2020	BUY	$89.45 - $129.85 $131,938 - $191,528	1,475 Added 73.46%	3,483 $416,000
Q1 2020 May 13, 2020	BUY	$70.23 - $144.31 $141,021 - $289,774	2,008 New	2,008 $201,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.